Exelixis Inc (EXEL)
22.16
+0.26
(+1.16%)
USD |
NASDAQ |
May 07, 16:00
22.16
0.00 (0.00%)
After-Hours: 17:07
Exelixis Free Cash Flow (Quarterly): 50.63M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 50.63M |
December 31, 2023 | -2.564M |
September 30, 2023 | 23.49M |
June 30, 2023 | 113.54M |
March 31, 2023 | 35.88M |
December 31, 2022 | -38.77M |
September 30, 2022 | 102.03M |
June 30, 2022 | 18.79M |
March 31, 2022 | 142.11M |
December 31, 2021 | 80.49M |
September 30, 2021 | 68.81M |
June 30, 2021 | 161.29M |
March 31, 2021 | 25.99M |
December 31, 2020 | 19.00M |
September 30, 2020 | 11.81M |
June 30, 2020 | 94.71M |
March 31, 2020 | 53.11M |
December 31, 2019 | 150.76M |
September 30, 2019 | 73.56M |
June 30, 2019 | 130.52M |
March 31, 2019 | 159.29M |
December 31, 2018 | 101.70M |
September 30, 2018 | 149.64M |
June 30, 2018 | 62.23M |
March 31, 2018 | 68.86M |
Date | Value |
---|---|
December 31, 2017 | 35.66M |
September 30, 2017 | 36.71M |
June 30, 2017 | 4.041M |
March 31, 2017 | 68.05M |
December 31, 2016 | 84.52M |
September 30, 2016 | -5.814M |
June 30, 2016 | -26.14M |
March 31, 2016 | 156.13M |
December 31, 2015 | -35.23M |
September 30, 2015 | -34.25M |
June 30, 2015 | -26.90M |
March 31, 2015 | -45.12M |
December 31, 2014 | -50.00M |
September 30, 2014 | -58.11M |
June 30, 2014 | -55.30M |
March 31, 2014 | -72.47M |
December 31, 2013 | -47.42M |
September 30, 2013 | -57.67M |
June 30, 2013 | -40.71M |
March 31, 2013 | -55.14M |
December 31, 2012 | -39.92M |
September 30, 2012 | -35.07M |
June 30, 2012 | -35.83M |
March 31, 2012 | -15.04M |
December 31, 2011 | -29.45M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-38.77M
Minimum
Dec 2022
161.29M
Maximum
Jun 2021
65.76M
Average
60.96M
Median
Free Cash Flow (Quarterly) Benchmarks
Regeneron Pharmaceuticals Inc | 1.351B |
Johnson & Johnson | 2.85B |
Merck & Co Inc | 2.229B |
Pfizer Inc | 4.196B |
Legend Biotech Corp | -102.49M |